PP
LHDX

Paloma Partners’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Paloma Partners’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-13,084
Closed -$113K – 2403
2021
Q4 		$113K Buy
+13,084
New +$83.2K ﹤0.01% 1740
2021
Q3 		– Sell
-19,312
Closed -$128K – 2085
2021
Q2 		$128K Buy
+19,312
New +$122K ﹤0.01% 1624

Other funds holding LHDX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
EV
Eclipse Ventures Palo Alto, California $2.57B AUM
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
CWA
Consilio Wealth Advisors Bellevue, Washington $417M AUM 20.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.12B AUM 38.14% 1-Year Est. Return

Paloma Partners's LHDX Position: Q1 2022 in Review

Paloma Partners sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2022, closing a stake of 13,084 shares — an estimated $113K sold.

Paloma Partners first reported a position in LHDX in Q2 2021 and held it in 2 quarters. The position peaked at $128K in Q2 2021. 40 funds tracked by Wall St. Rank hold LHDX as of Q1 2022.

  • Paloma Partners reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Paloma Partners sold 13,084 Lucira Health, Inc. Common Stock shares in Q1 2022, an estimated $113K.
  • Paloma Partners first reported a position in Lucira Health, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Paloma Partners's Lucira Health, Inc. Common Stock position peaked at $128K in Q2 2021.
  • 40 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2022.

Based on Paloma Partners's 13F filing for Q1 2022, filed 16 May 2022.